Pharmafile Logo

First Edition Translations Ltd

Founded in 1981, First Edition Translations Ltd is one of the UK’s oldest established translation agencies and a founder member of the Institute of Translation and Interpreting. Our team of professional medical translators are fluent in over 30 languages, ensuring your documents and materials are accurately translated.

First Edition offers diverse medical translation services that cover a broad range of materials, including:
Regulatory and legal documents
SPCs, PILs, labelling, treatment manuals
Clinical trials, assessments
Research studies, papers and abstracts
Information, manufacturing and marketing materials, IFUs
Specialist published materials, including catalogues, industry magazines and newsletters
Websites, apps and software

We value accuracy, reliability and outstanding quality, making us a trusted partner for all your medical and pharmaceutical translations. Adhering to the ISO 17100 standard, we can provide certification for our work upon request. If you’d like further advice, our friendly and multilingual project management team is always happy to help.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Atlas Translations Ltd

With Atlas Translations Ltd you get a service that is both personal and professional. This means that your message will be understood in the language and context you need it…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Company Details

6 Wellington Court, Wellington Street, Cambridge, CB1 1HZ, United Kingdom
+44 (0)1223 356 733

 Latest Content from PMHub 

Creative effectiveness: how to achieve tangible results

Chris Field, Director and Head of Creative Services at Blue Latitude Health, reveals what it takes to create winning creative campaigns that achieve results in the Pharma market.

Lucid’s Creative Services team grows

A vital part to delivering exceptional medical education programmes is the design of clever branding and engaging visual elements. Lucid Group pride themselves in the quality of their digital and...

Being social – harnessing the power of social media

With around 2.8 billion people using social media today, it’s a powerful force – one that encompasses a broad spectrum of websites and applications. In addition to well-known websites like Facebook,...

Leading Edge bolsters its delivery team

After earlier announcements that Lucid Partners was growing its medical writing team, Leading Edge (a Lucid Group company) proudly announces that it is strengthening its delivery team.Francesca Worthington joined Leading Edge...

How to build an online medical information service that resonates with your customers

Sourcing medical information is a top challenge for healthcare professionals in 2017. Here, Blue Latitude Health Associate Consultant Jiayi Chen gives you the inside scoop on how to build a...

You know more about your audience than you think

Our Digital Lead, Richard Springham, discusses the untapped resources of your digital tools and how they hold the key to targeting your audiences.

How will the NHS’s new medicines savings drive affect pharma?

Steve How and Sue Thomas, of Wilmington Healthcare, explore how pharma should engage with CCGs on prescribing saving targets

Pharma need to keep their ‘pull & push’ separate from their ‘inbound & outbound’

Is your pharma brand using the marketing terms ‘pull & push’ correctly?

A man walks into a surgery: The role of storytelling in pharma marketing

Communicating through stories can make your brand messages more meaningful, memorable and persuasive

Embracing the demands of the empowered ‘consumer-savvy’ patient by Ann Generlich

Our access to information, which is now constantly at our fingertips and the explosion of new technologies has shifted the buying power to increasingly ‘consumer-savvy’ patients. These are patients who choose...